BORTEZOMIB, MELPHALAN, PREDNISONE AND THALIDOMIDE (VMPT) VERSUS BORTEZOMIB, MELPHALAN AND PREDNISONE (VMP) IN ELDERLY NEWLY DIAGNOSED MYELOMA PATIENTS: A PROSPECTIVE, RANDOMIZED, PHASE III STUDY

被引：0
|
作者：
Palumbo, A. [1 ]
Bringhen, S. [1 ]
Rossi, D. [2 ]
Ria, R. [2 ]
Berretta, S. [2 ]
Offidani, M. [2 ]
Patriarca, F. [2 ]
Nozzoli, C. [2 ]
Levi, A. [2 ]
Guglielmelli, T. [2 ]
Benevolo, G. [2 ]
Callea, V. [2 ]
Liberati, A. M. [2 ]
Crippa, C. [2 ]
Di Renzo, N. [2 ]
Catalano, L. [2 ]
De Sabbata, G. [2 ]
Rizzi, R. [2 ]
Feo, C. [2 ]
Mazza, R. [2 ]
Farina, G. [2 ]
Spadano, A. [2 ]
Pisani, F. [2 ]
Podda, L. [2 ]
Aitoro, G. [2 ]
Magarotto, V. [1 ]
Astolfi, M. [1 ]
Di Raimondo, F. [2 ]
Gaidano, G.
Boccadoro, M. [1 ]
机构：
[1] AOU San Giovanni Battista, Turin, Italy
[2] Italian Multiple Myeloma Network, Gimema, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0472
引用
收藏
页码：190 / 191
页数：2
相关论文
共 50 条
  • [1] A Prospective, Randomized, Phase III Study of Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Versus Bortezomib, Melphalan and Prednisone (VMP) in Elderly Newly Diagnosed Myeloma Patients
    Palumbo, Antonio
    Bringhen, Sara
    Rossi, Davide
    Magarotto, Valeria
    Di Raimondo, Francesco
    Ria, Roberto
    Offidani, Massimo
    Nozzoli, Chiara
    Patriarca, Francesca
    Callea, Vincenzo
    Benevolo, Giulia
    Marasca, Roberto
    Guglielmelli, Tommasina
    Rizzo, Manuela
    Grasso, Mariella
    Petrucci, Maria Teresa
    Omede, Paola
    Gaidano, Gianluca
    Boccadoro, Mario
    [J]. BLOOD, 2008, 112 (11) : 243 - 243
  • [2] Overall Survival Benefit for Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance with Bortezomib-Thalidomide (VMPT-VT) Versus Bortezomib-Melphalan-Prednisone (VMP) in Newly Diagnosed Multiple Myeloma Patients
    Palumbo, Antonio
    Bringhen, Sara
    Rossi, Dmide
    Cavalli, Maide
    Ria, Roberto
    Gentilini, Silvia
    Patriarca, Francesca
    Nozzoli, Chiara
    Levi, Anna
    Guglielmelli, Tommasina
    Benevolo, Giulia
    Vincelli, Donatella
    Baldini, Luca
    Morabito, Fortunato
    Grasso, Mariella
    Marasca, Roberto
    Rizzo, Manuela
    Pautasso, Chiara
    Falcone, Antonietta Pia
    Gottardi, Daniela
    Montefusco, Vittorio
    Musolino, Caterina
    Cangialosi, Clotilde
    Mansueto, Giovanna
    Liberati, Anna Marina
    Magarotto, Valeria
    Omede, Paola
    Musto, Pellegrino
    Petrucci, Maria Teresa
    Boccadoro, Mario
    [J]. BLOOD, 2012, 120 (21)
  • [3] Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study
    Morabito, Fortunato
    Bringhen, Sara
    Larocca, Alessandra
    Wijermans, Pierre
    Victoria Mateos, Maria
    Gimsing, Peter
    Mazzone, Carla
    Gottardi, Daniela
    Omede, Paola
    Zweegman, Sonja
    Jose Lahuerta, Juan
    Zambello, Renato
    Musto, Pellegrino
    Magarotto, Valeria
    Schaafsma, Martijn
    Oriol, Albert
    Juliusson, Gunnar
    Cerrato, Chiara
    Catalano, Lucio
    Gentile, Massimo
    Isabel Turel, Ana
    Liberati, Anna Marina
    Cavalli, Maide
    Rossi, Davide
    Passera, Roberto
    Rosso, Stefano
    Beksac, Meral
    Cavo, Michele
    Waage, Anders
    San Miguel, Jesus
    Boccadoro, Mario
    Sonneveld, Pieter
    Palumbo, Antonio
    Offidani, Massimo
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (04) : 355 - 362
  • [4] Prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) for newly diagnosed elderly myeloma
    Renaud, Loic
    Leleu, Xavier
    [J]. HEMATOLOGIE, 2014, 20 (03): : 138 - 138
  • [5] Efficacy and safety of Daratumumab, Bortezomib, Melphalan, and Prednisone (D-VMP) versus Bortezomib, Melphalan, and Prednisone (VMP) in Chinese patients with newly diagnosed Multiple Myeloma: OCTANS
    Fu, Weijun
    Huang, Honghui
    Li, Wei
    An, Gang
    Cai, Zhen
    Jin, Jie
    Wang, Yafei
    Chim, Chor Sang
    Qi, Ming
    Wang, Jianping
    Song, Yang
    Jia, Bin
    Yang, Xue
    Liu, Wenyu
    Li, Yunan
    Zhang, Renyi
    Hou, Jian
    Wang, Jianxiang
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S125 - S125
  • [6] Bortezomib (Velcade)/Melphalan/Prednisone (VMP) Versus Velcade/Thalidomide/Prednisone (VTP) in Elderly
    Mateos, M. V.
    Martin, M. L.
    Gonzalez, Y.
    Lahuerta, J. J.
    Blade, J.
    Oriol, A.
    Martinez, J.
    Cibeira, M. T.
    de Paz, R.
    Terol, M. J.
    Garcia, J.
    Bengoechea, E.
    Martinez, R.
    Martin, A.
    de Arriba, F.
    Palomera, L.
    Hernandez, J. M.
    Bello, J. L.
    San Miguel, J.
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S25 - S25
  • [7] Melphalan, prednisone and thalidomide (MPT) versus melphalan and prednisone (MP) in newly diagnosed myeloma: Results of a prospective, randomized phase III study
    Bringhen, S.
    Liberati, A. M.
    Caravita, T.
    Falcone, A.
    Dore, F.
    Carubelli, A.
    Elice, F.
    Griso, L.
    Foli, C.
    Darbesio, A.
    Baraldi, A.
    Cellini, C.
    Annino, L.
    Piro, E.
    Magarotto, V
    Avonto, I
    Musto, P.
    Boccadoro, M.
    Palumbo, A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 135 - 136
  • [8] Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Followed by Maintenance with Bortezomib and Thalidomide for Initial Treatment of Elderly Multiple Myeloma Patients
    Palumbo, Antonio
    Bringhen, Sara
    Rossi, Davide
    Ria, Roberto
    Offidani, Massimo
    Patriarca, Francesca
    Nozzoli, Chiara
    Levi, Anna
    Guglielmelli, Tommasina
    Benevolo, Giulia
    Callea, Vincenzo
    Olivero, Barbara
    Morabito, Fortunato
    Grasso, Mariella
    Marasca, Roberto
    Rizzo, Manuela
    Falcone, Antonietta Pia
    Gottardi, Daniela
    Montefusco, Vittorio
    Musolino, Caterina
    Zambello, Renato
    Cangialosi, Clotilde
    Pietrantuono, Giuseppe
    Magarotto, Valeria
    Petrucci, Maria Teresa
    Musto, Pellegrino
    Ciccone, Giovannino
    Di Raimondo, Francesco
    Gaidano, Gianluca
    Boccadoro, Mario
    [J]. BLOOD, 2009, 114 (22) : 58 - 58
  • [9] Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment
    Morabito, Fortunato
    Gentile, Massimo
    Mazzone, Carla
    Rossi, Davide
    Di Raimondo, Francesco
    Bringhen, Sara
    Ria, Roberto
    Offidani, Massimo
    Patriarca, Francesca
    Nozzoli, Chiara
    Petrucci, Maria Teresa
    Benevolo, Giulia
    Vincelli, Iolanda
    Guglielmelli, Tommasina
    Grasso, Mariella
    Marasca, Roberto
    Baldini, Luca
    Montefusco, Vittorio
    Musto, Pellegrino
    Cascavilla, Nicola
    Majolino, Ignazio
    Musolino, Caterina
    Cavo, Michele
    Boccadoro, Mario
    Palumbo, Antonio
    [J]. BLOOD, 2011, 118 (22) : 5759 - 5766
  • [10] DARATUMUMAB PLUS BORTEZOMIB, MELPHALAN, AND PREDNISONE (D-VMP) VERSUS BORTEZOMIB, MELPHALAN, AND PREDNISONE (VMP) IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) PATIENTS (PTS) INELIGIBLE FOR TRANSPLANT: A PHASE 3 RANDOMIZED STUDY (ALCYONE)
    Mateos, M., V
    Dimopoulos, M. A.
    Cavo, M.
    Suzuki, K.
    Jakubowiak, A.
    Knop, S.
    Doyen, C.
    Lucio, P.
    Nagy, Z.
    Kaplan, P.
    Pou
    Cook, M.
    Grosicki, S.
    Crepaldi, A.
    Liberati, A. M.
    Campbell, P.
    Shelekhova, T.
    Yoon, S. S.
    Iosava, G.
    Fujisaki, T.
    Garg, M.
    Chiu, C.
    Wang, J.
    Carson, R.
    Crist, W.
    Deraedt, W.
    Nguyen, H.
    Qi, M.
    San-Miguel, J.
    [J]. HAEMATOLOGICA, 2018, 103 : 22 - 22
12345